Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?-Reference-Cited by-同舟云学术

Disability measurement in Multiple Sclerosis patients 55 years and older: What is the Expanded Disability Status Scale really telling clinicians?

Published:2021-04 Issue: Volume:49 Page:102724
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Lynch Sharon,Baker Sara,Nashatizadeh Muhammad,Thuringer Amanda,Thelen Joan,Bruce Jared

Funder

National Multiple Sclerosis Society

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference18 articles.

1. Polypharmacy cutoff and outcomes: Five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes;Gnjidic;J Clin Epidem,2012

2. Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support;Harris;J Biomed Inform,2009

3. Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis;Horton;Neuroepidemiology,2010

4. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population;Jyrkka;Pharm Drug Saf,2011

5. On the origin of Neurostatus;Kappos;Mult Scler Relat Disord,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late-onset multiple sclerosis: disability trajectories in relapsing–remitting patients of the Italian MS Registry;Journal of Neurology;2024-01-03

2. Well-being at midlife: Correlates of mental health in ambulatory menopausal women with multiple sclerosis;Multiple Sclerosis Journal;2023-09-16

3. Measuring disability in multiple sclerosis: the WHODAS 2.0;Quality of Life Research;2023-08-17

4. How to measure the treatment response in progressive multiple sclerosis: Current perspectives and limitations in clinical settings’;Multiple Sclerosis and Related Disorders;2023-08

5. Impact of aging on treatment considerations for multiple sclerosis patients;Frontiers in Neurology;2023-07-07